1. Home
  2. WWW vs HRMY Comparison

WWW vs HRMY Comparison

Compare WWW & HRMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wolverine World Wide Inc.

WWW

Wolverine World Wide Inc.

HOLD

Current Price

$16.45

Market Cap

1.5B

ML Signal

HOLD

Logo Harmony Biosciences Holdings Inc.

HRMY

Harmony Biosciences Holdings Inc.

HOLD

Current Price

$30.14

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WWW
HRMY
Founded
1883
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.6B
IPO Year
2002
2020

Fundamental Metrics

Financial Performance
Metric
WWW
HRMY
Price
$16.45
$30.14
Analyst Decision
Buy
Buy
Analyst Count
10
9
Target Price
$24.44
$44.11
AVG Volume (30 Days)
1.1M
650.7K
Earning Date
05-14-2026
05-07-2026
Dividend Yield
2.37%
N/A
EPS Growth
96.55
7.97
EPS
0.24
0.55
Revenue
$1,874,300,000.00
$868,453,000.00
Revenue This Year
$6.65
$19.75
Revenue Next Year
$5.50
$12.88
P/E Ratio
$68.40
$54.64
Revenue Growth
6.80
21.51
52 Week Low
$13.47
$25.52
52 Week High
$32.80
$40.87

Technical Indicators

Market Signals
Indicator
WWW
HRMY
Relative Strength Index (RSI) 51.02 46.73
Support Level $15.60 $28.26
Resistance Level $17.43 $30.96
Average True Range (ATR) 0.88 1.10
MACD -0.01 -0.17
Stochastic Oscillator 67.75 30.51

Price Performance

Historical Comparison
WWW
HRMY

About WWW Wolverine World Wide Inc.

Wolverine World Wide Inc is engaged in designing, manufacturing, sourcing, marketing, licensing, and distributing branded footwear, apparel, and accessories. The company's segment includes Active Group; Work Group; Corporate and Other. It generates maximum revenue from the Active Group segment. Active Group segment consists of Merrell footwear and apparel, Saucony footwear and apparel, Sweaty Betty activewear, and Chaco footwear.

About HRMY Harmony Biosciences Holdings Inc.

Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company has one reportable segment: rare neurological diseases. Its product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.

Share on Social Networks: